{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:55:36Z","timestamp":1770893736789,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1023\/a:1007887020332","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T11:54:20Z","timestamp":1040558060000},"page":"31-39","source":"Crossref","is-referenced-by-count":24,"title":["Coordinate Regulation of Metabolic Enzyme Encoding Genes During Cardiac Development and Following Carvedilol Therapy in Spontaneously Hypertensive Rats"],"prefix":"10.1007","volume":"14","author":[{"given":"Michael N.","family":"Sack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise S.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne K.","family":"Jonassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole D.","family":"Mj\u00f8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek M.","family":"Yellon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"251842_CR1","doi-asserted-by":"crossref","first-page":"10496","DOI":"10.1073\/pnas.92.23.10496","volume":"92","author":"AW Strauss","year":"1995","unstructured":"Strauss AW, Powell CK, Hale DE, et al. Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. Proc Natl Acad SciUSA 1995;92:10496-10500.","journal-title":"Proc Natl Acad SciUSA"},{"key":"251842_CR2","first-page":"913","volume":"330","author":"DP Kelly","year":"1993","unstructured":"Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1993;330:913-919.","journal-title":"N Engl J Med"},{"key":"251842_CR3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/01.CIR.99.10.1337","volume":"99","author":"A Mathur","year":"1999","unstructured":"Mathur A, Sims HF, Gopalakrishnan D, et al. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death. Circulation 1999;99:1337-1343.","journal-title":"Circulation"},{"key":"251842_CR4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jmcc.1996.0257","volume":"29","author":"T Tanaka","year":"1997","unstructured":"Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 1997;29:121-127.","journal-title":"J Mol Cell Cardiol"},{"key":"251842_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34.","journal-title":"Am J Cardiol"},{"key":"251842_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/377151a0","volume":"377","author":"EB Katz","year":"1995","unstructured":"Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4 [see comments]. Nature 1995; 377:151-155.","journal-title":"Nature"},{"key":"251842_CR7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1096\/fasebj.13.8.805","volume":"13","author":"B Binas","year":"1999","unstructured":"Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J. 1999;13:805-812.","journal-title":"FASEB J."},{"key":"251842_CR8","first-page":"27","volume":"50","author":"RJ. Bing","year":"1995","unstructured":"Bing RJ. The metabolism of the heart. Harvey Lect 1995;50: 27-70.","journal-title":"Harvey Lect"},{"key":"251842_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0146-2806(94)90008-6","volume":"19","author":"H. Taegtmeyer","year":"1994","unstructured":"Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 1994; 19:57-116.","journal-title":"Curr Probl Cardiol"},{"key":"251842_CR10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.ph.36.030174.002213","volume":"36","author":"JR Neely","year":"1974","unstructured":"Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974;36:413-459.","journal-title":"Annu Rev Physiol"},{"key":"251842_CR11","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/01.CIR.93.8.1549","volume":"93","author":"SL Henning","year":"1996","unstructured":"Henning SL, Wambolt RS, Schonekess BO, Lopaschuk GD, Allard MF. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation 1996;93:1549-1555.","journal-title":"Circulation"},{"key":"251842_CR12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI118561","volume":"97","author":"G Goodwin","year":"1996","unstructured":"Goodwin G, Ahmad F, Taegtmeyer H. Preferred oxidation of glycogen in isolated working rat hearts. J Clin Invest 1996; 97:1409-1416.","journal-title":"J Clin Invest"},{"key":"251842_CR13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/ajplegacy.1970.218.1.153","volume":"218","author":"SP Bishop","year":"1970","unstructured":"Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. AmJ Physiol 1970;218:153-159.","journal-title":"AmJ Physiol"},{"key":"251842_CR14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.HYP.11.5.416","volume":"11","author":"H Taegtmeyer","year":"1988","unstructured":"Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 1988;11:416-426.","journal-title":"Hypertension"},{"key":"251842_CR15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1253\/jcj.40.1119","volume":"40","author":"K Kawamura","year":"1976","unstructured":"Kawamura K, Kashii C, Imamura K. Ultrastructural changes in hypertrophied myocardium of spontaneously hypertensive rats. Jpn Circ J 1976;40:1119-1145.","journal-title":"Jpn Circ J"},{"key":"251842_CR16","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","volume":"94","author":"MN Sack","year":"1996","unstructured":"Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid enzyme encoding gene expression is downregulated in the failing heart. Circulation 1996;94:2837-2842.","journal-title":"Circulation"},{"key":"251842_CR17","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/nar\/13.7.2485","volume":"13","author":"JY Tso","year":"1985","unstructured":"Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985;13:2485-2502.","journal-title":"Nucleic Acids Res"},{"key":"251842_CR18","doi-asserted-by":"crossref","first-page":"R364","DOI":"10.1152\/ajpcell.1992.262.4.C1031","volume":"262","author":"K Schwartz","year":"1992","unstructured":"Schwartz K, Boheler K, de la Bastie D, Lompre AM, Mercadier JJ. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol 1992; 262:R364-R369.","journal-title":"Am J Physiol"},{"key":"251842_CR19","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/cvr\/27.7.1140","volume":"27","author":"M van Bilsen","year":"1993","unstructured":"van Bilsen M, Chien KR. Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovas Res 1993;27:1140-1149.","journal-title":"Cardiovas Res"},{"key":"251842_CR20","first-page":"17","volume":"1","author":"MN Sack","year":"1998","unstructured":"Sack MN, Kelly DP. The energy substrate switch during the development of heart failure: Gene regulatory mechanisms (review). Int J Mol Med 1998;1:17-24.","journal-title":"Int J Mol Med"},{"key":"251842_CR21","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.1016\/S0021-9258(19)47245-1","volume":"264","author":"DP Kelly","year":"1989","unstructured":"Kelly DP, Gordon JI, Alpers R, Strauss AW. The tissuespecifi c expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J Biol Chem 1989;264:18921-18925.","journal-title":"J Biol Chem"},{"key":"251842_CR22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1097-0185(199706)248:2<233::AID-AR10>3.0.CO;2-Q","volume":"248","author":"MW Knaapen","year":"1997","unstructured":"Knaapen MW, Vrolijk BC, Wenink AC. Ultrastructural changes in the myocardium in the embryonic rat heart. Anat Rec 1997;248:233-241.","journal-title":"Anat Rec"},{"key":"251842_CR23","first-page":"E548","volume":"266","author":"C Postic","year":"1994","unstructured":"Postic C, Leturque A, Printz RL, et al. Development and regulation of glucose transporter and hexokinase expression in rat. Am J Physiol 1994;266:E548-E559.","journal-title":"Am J Physiol"},{"key":"251842_CR24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.CIR.99.4.578","volume":"99","author":"C Depre","year":"1999","unstructured":"Depre C, Vanoverschelde J-LJ, Taegtmeyer H. Glucose and the heart. Circulation 1999;99:578-588.","journal-title":"Circulation"},{"key":"251842_CR25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/3253","volume":"4","author":"C Depre","year":"1998","unstructured":"Depre C, Shipley GL, Chen W, et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 1998;4:1269-1275.","journal-title":"Nat Med"},{"key":"251842_CR26","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1073\/pnas.94.12.6438","volume":"94","author":"MN Sack","year":"1997","unstructured":"Sack MN, Disch DL, Rockman HA, Kelly DP. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci 1997; 94:6438-6443.","journal-title":"Proc Natl Acad Sci"},{"key":"251842_CR27","doi-asserted-by":"crossref","first-page":"26078","DOI":"10.1074\/jbc.273.40.26087","volume":"273","author":"DJ Discher","year":"1998","unstructured":"Discher DJ, Bishopric NH, Wu X, Peterson CA, Webster KA. Hypoxia regulates b-enolase and pyruvate kinase-M promoters by modulating Sp1\/Sp3 binding to a conserved GC element. J Biol Chem 1998;273:26078-26093.","journal-title":"J Biol Chem"},{"key":"251842_CR28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/10641969409067947","volume":"16","author":"EH Ohlstein","year":"1994","unstructured":"Ohlstein EH, Vickery L, Arleth A, et al. Carvedilol, a novel cardiovascular agent, inhibits development of vascular and ventricular hypertrophy in spontaneously hypertensive rats. Clin Exp Hypertens 1994;16:163-177.","journal-title":"Clin Exp Hypertens"},{"key":"251842_CR29","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","volume":"94","author":"MR Bristow","year":"1996","unstructured":"Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996;94:2807-2816.","journal-title":"Circulation"},{"key":"251842_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1007789519005","volume":"12","author":"M Yoshiyama","year":"1998","unstructured":"Yoshiyama M, Takeuchi K, Hanatani A, et al. Effect of cilazapril on ventricular remodeling assessed by Dopplerechocardiographic assessment and cardiac gene expression. Cardiovasc Drugs Ther 1998;12:57-70.","journal-title":"Cardiovasc Drugs Ther"},{"key":"251842_CR31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s001250050999","volume":"41","author":"JL Leahy","year":"1998","unstructured":"Leahy JL, Chen C, Rhodes CJ. How is the insulin content regulated in nondiabetic hyperinsulinaemic, insulin resistant states? Study of spontaneously hypertensive rats. Diabetologia 1998;41:855-859.","journal-title":"Diabetologia"},{"key":"251842_CR32","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1006\/jmcc.1994.1155","volume":"26","author":"ME Christe","year":"1994","unstructured":"Christe ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol 1994;26:1371-1375.","journal-title":"J Mol Cell Cardiol"},{"key":"251842_CR33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/5013","volume":"21","author":"TJ Aitman","year":"1999","unstructured":"Aitman TJ, Glazier AM, Wallace CA, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999;21:76-83.","journal-title":"Nat Genet"},{"key":"251842_CR34","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00005344-199424060-00001","volume":"24","author":"O Hansen","year":"1994","unstructured":"Hansen O, Johansson BW, Nilsson-Ehle P, et al. Effects of carvedilol on the metabolic, hemodynamic, and electrocardiographic responses to increased plasma epinephrine in normal subjects. J Cardiovasc Pharmacol 1994;24:853-859.","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007887020332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007887020332\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007887020332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:24:34Z","timestamp":1751052274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007887020332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["251842"],"URL":"https:\/\/doi.org\/10.1023\/a:1007887020332","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}